Adaptor protein 2 sigma subunit (AP2S1) variants associated with neurodevelopmental disorders

Mark Stevenson,Asha L Bayliss,Victoria J Stokes,Katherine A English,Kreepa G Kooblall,Roman Fischer,Raphael Heilig,Iolanda Vendrell,Maria E W A Albers,Meghan Bartos,Amber Begtrup,Alexia Bourgois,Rebecca Buchert,David J Carey,Deanna A Carere,Amanda Carnevale,Kristl G Claeys,Benjamin Cogne,Gregory Costain,Nicole de Leeuw,Anne-Sophie Denommé-Pichon,Elizabeth J Donner,Eftychia Drogouti,David A Dyment,Balram Gangaram,Tobias B Haack,Jeremy S Haley,Solveig Heide,Ralf A Hussain,Bertrand Isidor,Louise Izatt,Adeline Jacquinet,Jane Juusola,Juliette J Kahle,Boris Keren,Eric W Klee,Evgenia Kokosali,Brendan C Lanpher,Erica L Macke,Elysa J Marco,Kirsty McWalter,Bryce A Mendelsohn,Aubrey Milunshy,Matthew Osmond,Amelie Piton,Angelika Riess,Valentin Ruault,Patrick Rump,Sarah Schuhmann,Amelle L Shillington,Diane T Smelser,Lot Snijders Blok,Frederic Tran Mau-Them,Christos Tsakalidis,Abigail Turnwald,Koen L I Van Gassen,Kristof Van Schil,Georgia Vasileiou,Marissa Vawter-Lee,Marjolaine Willems,Marjolein H Willemsen,Lily C Wong-Kisiel,Antje Wonneberger,Ioannis Zaganas,Genomics England Research Consortium,Fadil M Hannan,Kate E Lines,Rajesh V Thakker
DOI: https://doi.org/10.1101/2024.07.22.24310683
2024-07-22
Abstract:Adaptor-Related Protein Complex 2 Sigma-1 Subunit (AP2S1) encodes AP2σ2, which forms part of the heterotetrameric AP2 complex that is composed of α, β2, μ2, and σ2 subunits and has a pivotal role in clathrin-mediated endocytosis (CME). AP2S1 variants involving the Arg15 residue are associated with familial hypocalciuric hypercalcaemia type 3 (FHH3). Here, we report 5 different AP2S1 variants (AP2σ2: p.Arg10Trp, p.Arg10Gln, p.Lys18Glu, p.Lys18Asn and p.Arg61His) in 26 patients with neurodevelopmental delay, of whom >70% had epilepsy, 50% had brain abnormalities, and none had hypercalcaemia. All 5 variants decreased cell viability, 4 reduced CME transferrin uptake, and 4 disrupted interactions with other AP2 complex subunits, thereby affecting AP2 formation. Furthermore, AP2σ2 p.Arg10Trp had reduced interactions with 44 human proteins including intersectin 1, a component required for clathrin-coated pit formation and synaptic vesicle dynamics in neurones. Thus, our results show that AP2σ2 variants may disrupt CME and be associated with neurodevelopmental disorders.
What problem does this paper attempt to address?